Sfoglia per Rivista
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi
2016-01-01 Sacchi, S; Marcheselli, R; Bari, A; Buda, G; Molinari, Al; Baldini, L; Vallisa, D; Cesaretti, M; Musto, P; Ronconi, S; Specchia, G; Silvestris, F; Guardigni, L; Ferrari A, ; Chiapella, A; Carella, Am; Santoro, A; Di Raimondo, F; Marcheselli, L; Pozzi, S
Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study
2008-01-01 Sacchi, S; Marcheselli, L; Bari, A; Marcheselli, R; Pozzi, S; Gobbi, Pg; Angrilli F, ; Brugiatelli, M; Musto, P; Federico, M
Thalidomide abolishes transfusion-dependence in selected patients with myelodysplastic syndromes
2002-01-01 Musto, P; Falcone, A; Sanpaolo, G; Bisceglia, M; Matera, R; Carella, Am
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network
2014-01-01 van de Donk, Nw; Palumbo, A; Johnsen, He; Engelhardt, M; Gay, F; Gregersen, H; Hajek, R; Kleber, M; Ludwig, H; Morgan, G; Musto, P; Plesner, T; Sezer, O; Terpos, E; Waage, A; Zweegman, S; Einsele, H; Sonneveld, P; Lokhorst, Hm
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi | 1-gen-2016 | Sacchi, S; Marcheselli, R; Bari, A; Buda, G; Molinari, Al; Baldini, L; Vallisa, D; Cesaretti, M; Musto, P; Ronconi, S; Specchia, G; Silvestris, F; Guardigni, L; Ferrari A, ; Chiapella, A; Carella, Am; Santoro, A; Di Raimondo, F; Marcheselli, L; Pozzi, S | |
| Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study | 1-gen-2008 | Sacchi, S; Marcheselli, L; Bari, A; Marcheselli, R; Pozzi, S; Gobbi, Pg; Angrilli F, ; Brugiatelli, M; Musto, P; Federico, M | |
| Thalidomide abolishes transfusion-dependence in selected patients with myelodysplastic syndromes | 1-gen-2002 | Musto, P; Falcone, A; Sanpaolo, G; Bisceglia, M; Matera, R; Carella, Am | |
| The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | 1-gen-2014 | van de Donk, Nw; Palumbo, A; Johnsen, He; Engelhardt, M; Gay, F; Gregersen, H; Hajek, R; Kleber, M; Ludwig, H; Morgan, G; Musto, P; Plesner, T; Sezer, O; Terpos, E; Waage, A; Zweegman, S; Einsele, H; Sonneveld, P; Lokhorst, Hm |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile